The study involved implementing a comprehensive program and real-time bundle compliance dashboard at an academic medical center to improve compliance and reduce ventilator-associated complications. The researchers then assessed the program’s effect in six adult intensive care units.
Following the implementation of the program:
1. VAP rates in all ICUs combined decreased from 19.5 to 9.2 VAPs per 1,000 ventilator-days
2. Bundle compliance increased from 23 percent in August 2007 to 83 percent in June 2011
3. The overall ICU VAP rate saw a significant month to month decrease of 3.28/1,000 ventilator-days
4. The VAP rate decreased significantly at a rate of 0.20/1,000 ventilator-days per month; and
5. Among all adult ICUs combined, improved bundle compliance was moderately correlated with monthly VAP rate reductions
Ultimately, the prevention program that included a compliance dashboard was associated with considerable sustained decreases in VAP rates and an increase in bundle compliance among adult ICU patients.
More articles on pneumonia:
Steroid therapy may benefit pneumonia patients: 3 study findings
AHRQ: Inpatient death rates down for 4 high-volume conditions
Research links liver to pneumonia, sepsis susceptibility
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
